Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price184.74 USD
Fair value219.00
Ethical score74.0/100
RatingOPPORTUNITY
Our investment reviews on this name
2026-07-18Read Markup167.04+10.6% to today ✓
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
NetApp holds its Markup at $184.74. Consolidating, no directional conviction, held for 1 days.
As held on the ledger · 2026-09-09
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 1 days
Price at the screen
$184.74
Valuation
26.13 trailing · 16.79 forward price to earnings
Values screen
PASS· score 74.0
Beta
1.43
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
32.26%
Below 33%
Interest-bearing debt is just 32.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.85%
Below 33%
Cash held in interest-bearing accounts and securities is 0.9% of assets, under the one-third limit.
Pass
Receivables
36.85%
Below 49%
Money owed to the company is 36.8% of assets, under the 49% limit.
Pass
Revenue purity
1.70%
Below 5%
Only 1.7% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 19% discount to our $219.00 fair value, moderate competitive moat, 29.90% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 18.5% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus Buy. The average target sits +6% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Hybrid tools keeping enterprise data flowing
Picture a retailer or bank moving customer records between its own servers and the cloud without losing a byte. NetApp supplies the hybrid systems that make the switch work. Revenue is rising 12 percent a year, margins sit at 18 percent, and return on equity reaches 107 percent, all at a forward multiple of 16.7 times.
Our fair value sits 22 percent above the current price with a buy consensus from 16 analysts and a median target of 180 dollars. The moderate moat and ethical pass line up with an opportunity rating.
Risk sits in that moderate competitive position and exposure to enterprise budget cycles that can turn quickly. Any slowdown in tech spending would test the growth rate fast.
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NTAP trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-02Markup$192.27+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-01Markup$192.27+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-31Markup$192.27+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Markup$192.27+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-29Markup$192.27+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-28Markup$192.27+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-27Markup$192.27+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-26Markup$192.27+3.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-07Markup$186.60+11.7%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118.
2026-07-18Markup$167.04+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it buy, with a mean price target of $118.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.